Cape Coral, FL, United States of America

Lester J Wu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gongwin Biopharm Co., Ltd. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lester J Wu. Retrieved from https://idiyas.com/inventor/lester-j-wu-lleoz9zi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lester J Wu: Innovator in Pharmaceutical Composition

Introduction

Lester J Wu is a notable inventor based in Cape Coral, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that exhibit anti-tumor activity. His work is crucial in the ongoing fight against cancer.

Latest Patents

Lester J Wu holds a patent for a pharmaceutical composition that exhibits anti-tumor activity. This composition comprises para-toluenesulfonamide (PTS) and a pharmaceutically acceptable carrier. The invention is specifically designed for treating squamous-cell carcinoma. Additionally, it provides methods for treating patients suffering from cancer and inhibiting tumor growth.

Career Highlights

Wu is associated with Gongwin Biopharm Co., Ltd., where he applies his expertise in pharmaceutical development. His innovative approach has led to advancements in cancer treatment, showcasing his commitment to improving patient outcomes.

Collaborations

Lester J Wu has collaborated with notable colleagues, including Nanshan Zhong and Longjiang Li. Their combined efforts contribute to the advancement of pharmaceutical research and development.

Conclusion

Lester J Wu's contributions to the field of pharmaceuticals, particularly in anti-tumor compositions, highlight his role as an innovator. His work continues to impact cancer treatment positively, making him a significant figure in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…